China SXT Pharmaceuticals Inc (NASDAQ:SXTC)’s traded shares stood at 3.81 million during the last session, with the company’s beta value hitting 1.12. At the close of trading, the stock’s price was $0.39, to imply an increase of 12.49% or $0.04 in intraday trading. The SXTC share’s 52-week high remains $6.39, putting it -1538.46% down since that peak but still an impressive 23.08% since price per share fell to its 52-week low of $0.30. The company has a valuation of $1.53M, with an average of 0.65 million shares in intraday trading volume over the past 10 days and average of 834.68K shares over the past 3 months.
China SXT Pharmaceuticals Inc (NASDAQ:SXTC) trade information
After registering a 12.49% upside in the last session, China SXT Pharmaceuticals Inc (SXTC) has traded red over the past five days. The 5-day price performance for the stock is 9.94%, and -2.09% over 30 days. With these gigs, the year-to-date price performance is -90.55%. Short interest in China SXT Pharmaceuticals Inc (NASDAQ:SXTC) saw shorts transact 72132.0 shares and set a 0.52 days time to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
SXTC Dividends
China SXT Pharmaceuticals Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Going by data provided on Oct 31, 2023 , Fidelity NASDAQ Composite Index Fund holds roughly 54.0 shares. This is just over 0.00% of the total shares, with a market valuation of $21.0
